CHEMED CORP Q3 FY2026 earnings call

• VITAS Performance: Driven by a 9.4% increase in days of care and a ~2.2% increase in the weighted average Medicare reimbursement rate. High-acuity days declined slightly, but overall volume growth was strong. Cost containment efforts, including reduced SG&A ($2.1 million decrease) and optimized staffing via electronic tools, supported margin expansion despite wage pressures.
• Roto-Rooter Growth & Challenges: Same-store sales exceeded expectations at 5.5%. However, margins were pressured by a shift in lead sources, with paid leads increasing to 60% of total leads (from 56% in Q3 2025), resulting in $4.3 million higher marketing spend. Fuel costs also rose by $1.4 million.
• Strategic Acquisitions: Roto-Rooter reacquired franchise territories in California for approximately $62.5 million, adding over 12 million people in population. These acquisitions are expected to boost top-line revenue rapidly but will dilute short-term EBITDA margins as they operate at single-digit margins before integration into the owned-and-operated model. $96 million was spent on franchise reacquisitions in 2026.
• Operational Efficiency: Centralization of water restoration billing and collections improved collections, reducing write-offs by $2.9 million. Average price per job in water restoration increased 2.8%, reversing a multi-quarter downward trend.
• Capital Allocation: The company repurchased 125,000 shares for $66 million in Q3. Over the trailing 12 months, 1.235 million shares were bought back. Strong cash flow from operations (> $229 million YTD) supports continued share repurchases and strategic acquisitions.

• VITAS Healthcare: Net revenue of $457.4 million (up 12.2% YoY), representing a significant portion of total consolidated revenue. Adjusted EBITDA excluding Medicare cap was $92.5 million (up 31.4% YoY) with a margin of 20.2%. Admissions grew 7.2% to 18,995.
• Roto-Rooter: Total branch revenue of $218.7 million ($59.9 million commercial + $158.8 million residential), up 7.5% YoY. Same-store revenue increased 5.5%. Adjusted EBITDA was $48.2 million (down 2.5% YoY) with a margin of 20.6%, impacted by higher marketing costs and fuel expenses.

• Full Year 2026 Adjusted EPS: Management expects to finish the year at or slightly above the high end of the guidance range previously provided in Q2 2026. This reflects outperformance in VITAS offsetting lower-than-guided performance in Roto-Rooter's third quarter.
• Outlook: No specific segment-level guidance was updated, but management signaled confidence in meeting the upper bound of the full-year EPS target without needing to revise guidance upward further.

• Marketing Cost Inflation: A structural shift toward paid leads (now 60% of total) due to declining organic internet search visibility is pressuring Roto-Rooter margins. Google’s advertising practices and the rise of AI-driven searches add uncertainty to future lead acquisition costs.
• Acquisition Margin Dilution: Recent franchise acquisitions operate at significantly lower EBITDA margins (single digits) compared to owned branches (~20%), creating short-term headwinds for consolidated Roto-Rooter profitability.
• Regulatory Scrutiny: Increased federal and state audits regarding fraud and abuse have led to higher contractual allowances and temporary write-offs, though management maintains a strong track record of reversing these claims.
• Wage Pressure: While hiring remains stable, nurse wage inflation exceeds reimbursement growth rates, necessitating continuous cost containment in non-clinical areas to protect margins.

Q: Analyst asked about nursing recruitment challenges and wage inflation given strong demand. / A: Vitas reports no difficulty in hiring nurses or significant wage pressures that impede growth. CEO McNamara noted that hospice nursing wages remain relatively stable compared to hospital roles, adhering to an 'iron law' where field-level expenses stay in the mid-60s percent of reimbursement. CFO Witzeman added that while general nurse wages rise faster than reimbursements, back-office cost containment mitigates this impact on EBITDA margins.

Q: Analyst inquired about the Roto-Rooter franchise acquisition pipeline and its impact on margins. / A: Management indicated major metropolitan areas are largely covered, with action shifting to smaller markets and independent contractor tuck-ins. The recent California acquisition adds $30-$35 million in estimated first-year revenue but contributes less than $4 million in EBITDA initially due to sub-10% pre-acquisition margins. Margins are expected to improve over 12-18 months as operations integrate into the owned-and-operated model.

Q: Analyst questioned the rationale behind maintaining high-end EPS guidance despite Roto-Rooter underperformance. / A: CFO Witzeman explained that Vitas outperformed by ~30 cents in Q3, allowing the company to meet the upper guidance range even if Q4 performs as guided. Management aims to avoid quarterly guidance revisions, signaling confidence that the combined unit performance will sustain the high-end target without needing further upward adjustments.

Q: Analyst asked if AI tools like ChatGPT pose a risk to Roto-Rooter’s lead generation by promoting DIY solutions. / A: Management dismissed this as a minor headwind, noting their core business involves emergency, complex issues (e.g., sewage backups) rather than simple DIY tasks like fixing faucets. CEO McNamara emphasized that brand strength ensures repeat customers seek them directly, and the strategy to counteract marketing costs lies in growing the average price per job.

Q: Analyst sought clarity on whether Vitas is gaining market share amid regulatory scrutiny of competitors. / A: CEO Wherley stated growth has been balanced across Florida and non-Florida markets, not just new starts. He highlighted a competitive advantage in compliance, suggesting that regulators’ focus on waste/fraud may inadvertently benefit reputable providers like Vitas who can withstand audits better than smaller, non-profit competitors.